Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

NCT00222235 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: d-cycloserine
DRUG: glycine
DRUG: placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]